CHICAGO--(BUSINESS WIRE)--Sheridan Capital Partners (“Sheridan”) announced today its investment in Empower Physical Therapy (“Empower PT” or the “Company”), a physical therapy practice management company. Empower PT is the by-product of a dedicated group of physical therapy founder-owners unifying behind a shared vision - empowering health and wellbeing through exceptional, unmatched care. Empower PT is headquartered in Phoenix, Arizona, and currently operates outpatient physical therapy clinics across the Southwest U.S.
“Empower PT brings together a team of high-quality, passionate, and community-oriented therapists all focused on strengthening lives through helping others,” said Steve DiPaola, Chief Executive Officer of Empower Physical Therapy. “We are fortunate to partner with the experienced professionals at Sheridan, who bring a history and expertise in building leading healthcare services businesses. We look forward to growing Empower PT together.”
“It is a pleasure to partner with Steve and the entire team at Empower PT,” said Jonathan Lewis, Partner of Sheridan Capital Partners. “We have found a motivated team and an energized culture and we believe they are poised for continued growth and great success.”
“This partnership reinforces Sheridan’s investment strategy of finding and supporting successful, founder-led businesses at a key inflection point of growth,” added Sean Dempsey, Partner of Sheridan Capital Partners. “Empower PT is already a leader in the Southwest U.S., and we plan to amplify and accelerate their on-going success.”
The transaction was led by Jonathan Lewis, Sean Dempsey, Nicholas Rowland, Jonathan Gavron, and Matt Hinshaw at Sheridan Capital Partners. Oxford Finance provided debt financing for the transaction. McGuireWoods LLP served as legal counsel to Sheridan Capital Partners. Terms of the transaction were not disclosed.
About Sheridan Capital Partners
Sheridan Capital Partners,
headquartered in Chicago, Illinois, focuses on making private equity
investments in growth-oriented lower middle market healthcare companies
with enterprise values between $20 million and $150 million.